Pharmacogenomics

Pharmacogenomics is the study of the role of genetics in drug response. It deals with the effect of genetic variation on drug response in patients by associating gene expression or single-nucleotide polymorphisms with drug absorption, distribution, metabolism and elimination, as well as drug receptor target effects. pharmacogenomics aims to develop rational means to optimize drug therapy, with respect to the patients' genotype, to ensure maximum efficacy with minimal adverse effects. Pharmacogenetics focuses on single drug-gene interactions. It helps in Improve drug safety, and reduce ADRs,Tailor treatments to meet patients' unique genetic pre-disposition, identifying optimal dosing.

 

  • Genome sequencing
  • Clinical Pharmacogenomics
  • Genomics for optimized medical prescription
  • More accurate methods of determining appropriate drug dosages
  • Advanced screening for disease

Related Conference of Pharmacogenomics

October 10-11, 2022

International Conference on Biosimilars & Pharmaceuticals

Amsterdam, Netherlands
October 24-25, 2022

5th International Conference on Glycobiology

Paris, France
October 27-28, 2022

2nd Annual Summit on Advanced Bionics

Rome, Italy
November 14-15, 2022

4th International Conference on Biochemistry

London, UK
November 14-15, 2022

4th International Conference on Nucleic Acids

London, UK
February 22-23, 2023

International Bio Summit and Expo

London, UK
April 17-18, 2023

13th World Glycobiology Congress

Rome, Italy
October 30-31, 2023

14th World Congress on Cell & Tissue Science

Rome, Italy

Pharmacogenomics Conference Speakers

Recommended Sessions

Related Journals

Are you interested in